The quest for the treatment of cognitive impairment: α₇ nicotinic and α₅ GABA_A receptor modulators

Author： Romanelli Maria Novella Gualtieri Fulvio

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.11, 2007-11, pp. : 1365-1377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

By Geerts Hugo

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 59-65

Informa Healthcare

Access to resources Recommend Favorite

The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators

By Sun Miao-Kun

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 999-1010

Informa Healthcare

Access to resources Recommend Favorite

GABAA Receptor Subtype-Selective Modulators. II. 5-Selective Inverse Agonists for Cognition Enhancement

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 9, 2011-05 ,pp. : 1203-1214

Bentham Science Publishers

Access to resources Recommend Favorite

α-Subunit selective modulators of GABAA receptor function as CNS therapeutics

By Hamilton Niall M Cooke Andrew J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1491-1501

Informa Healthcare

Access to resources Recommend Favorite

Selective Modulators of 5-Containing GABAA Receptors and their Therapeutic Significance

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 735-746

Bentham Science Publishers

Access to resources Recommend Favorite